Pacific Biosciences of California (NASDAQ:PACB) Rating Increased to Sell at StockNews.com
StockNews.com upgraded shares of Pacific Biosciences of California (NASDAQ:PACB – Free Report) to a sell rating in a research note issued to investors on Tuesday morning. Other research analysts have also issued reports about the stock. Piper Sandler reiterated a “neutral” rating and issued a $2.00 target price (down from $2.50) on shares of Pacific […]
StockNews.com upgraded shares of Pacific Biosciences of California (NASDAQ:PACB – Free Report) to a sell rating in a research note issued to investors on Tuesday morning. Other research analysts have also issued reports about the stock. Piper Sandler reiterated a “neutral” rating and issued a $2.00 target price (down from $2.50) on shares of Pacific […]
